JEFFREY KAUPPI: Open Payments
NPI 1720081821 · DICKSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,118 in 105 payments from 22 companies in 2025. Trend: 2023 $2,461 · 2024 $2,375 · 2025 $2,118
Food & beverage: $2,118
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $441 |
| Lilly USA, LLC | 13 | $244 |
| ABBVIE INC. | 14 | $244 |
| PFIZER INC. | 11 | $189 |
| AstraZeneca Pharmaceuticals LP | 8 | $142 |
| Abbott Laboratories | 5 | $109 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $75 |
| Axsome Therapeutics, Inc. | 3 | $73 |
| Corcept Therapeutics | 2 | $71 |
| Astellas Pharma US Inc | 3 | $69 |
Products named: Ozempic, MOUNJARO, Rybelsus, QULIPTA, NURTEC ODT, FREESTYLE LIBRE 3, FARXIGA, Kerendia.
Industry payments across TN — which companies pay providers there.
